2025年第17届国际骨髓增殖性肿瘤大会

◆ 会议时间：2025年11月6-7日
◆ 会议地点：美国 纽约

◆ 会议简介：

2025年第17届骨髓增殖性肿瘤国际大会将于2025年11月6-7日在美国纽约举行，会议将为来自世界各地的与会者提供及时、相关和有意义的有关骨髓增殖性肿瘤诊断和治疗方面的信息。未经许可禁止复制摘录转载本站任何内容-领域国际医学会议网(lingyuint.com)

17th International Congress on Myeloproliferative Neoplasms (MPN Congress) 2025

Date:
November 6-7, 2025

Venue:
New York Marriott at the Brooklyn Bridge
New York, USA

摘要征集-Abstract Submission：

Submission Deadline: September 22, 2025

Participants interested in presenting data should submit abstracts by email to abstracts@mpncongress.com on or before September 22, 2025

The 17th International Congress on Myeloproliferative Neoplasms Organizing Committee encourages participants to submit an abstract for publication in the program book and for poster presentation during the event. In addition, the author of the “best” abstract (as determined by the Abstract Committee) will be awarded a travel grant (for airfare, ground transportation and lodging) and will have the opportunity to give an oral presentation of their poster/abstract during the general session.

The committee seeks original papers that address basic or clinical issues specifically related to the diagnosis or management of patients with myeloproliferative neoplasms or chronic myeloid leukemia.

Participants interested in presenting data should submit abstracts by email to abstracts@mpncongress.com on or before September 22, 2025. Abstracts are subject to acceptance by the Abstract Committee. Acceptance notifications and guidelines for poster presentations will be sent by October 16, 2025. All those accepted for abstract/poster presentation will receive complimentary registration to attend the conference. Note that reimbursement for travel and hotel expenses is not provided.

Abstract Guidelines

– Abstracts must be written in English.

– Accepted format: Word document, 500 word count limit

– May include up to 3 figures and/or tables

– Use a concise title.

– List affiliations of author(s) as briefly as possible, with city, state and country

– Place an asterisk (*) before the name of the presenting author.

– Use standard and well-accepted abbreviations.

– When using references, use standard and well-accepted formats.

– Abstract content should be single-spaced, typed in lower case and contain:

     > Introduction/Background/Significance

     > Description/Materials and Methods/Objectives

     > Results/Main Outcome Measure(s)

     > Conclusion(s)

(For Abstracts of Clinical Trials in Progress: Background, Design and Methods, Status)

– Abstracts must represent original work, although previously published work may be used to fulfill this requirement.

– Presentations are not disqualified from submission to the annual ASH meeting.

Submission Deadline: September 22, 2025

Note: A confirmation email will be sent to you within 24 hours of receiving your abstract submission.  If you do not receive a confirmation email within this timeframe, please contact us at heather@meltonmeded.com or call 1.512.619.5534 for assistance.

Dear Colleagues,

We are delighted to invite you to attend the 17th International Congress on Myeloproliferative Neoplasms convening on November 6-7, 2025 at the New York Marriott-Brooklyn Bridge in Brooklyn, New York. This event, founded in 2001, and now held annually, serves as a cornerstone for advancing education about the myeloproliferative neoplasms (MPN).

The two-day program features world-renowned faculty and offers CME credits for physicians and CE credits for nurse practitioners, physician assistants, and nurses. With an emphasis on robust faculty interaction and active audience engagement, the MPN Congress features an interactive format with a Q&A session following each speaker’s presentation. In addition, based on positive feedback from the last Congress, we will continue both the debate session and the nurse-led session.

Participants can also enjoy numerous networking opportunities and one-on-one discussions with the faculty and other attendees, promoting collaboration and knowledge-sharing among professionals in the MPN field.

The MPN Congress encourages abstract submissions (sanctioned by the ASH), offering an excellent platform for fellows, faculty and others to display their clinical or scientific research through a poster forum during the Congress. Awards will be presented for outstanding abstracts, and the abstract selected as “best” will be highlighted with an oral presentation during the general session.

There is a time for every season.  At this year’s Congress, Dr. Jerry Spivak, who has Co-Chaired the Congress since its founding in 2001, will become Chair, and Dr. Richard Silver will become Chair Emeritus.  We are also pleased to announce that Dr. Naveen Pemmaraju and Dr. John Mascarenhas, who have served on the Congress Program Committee, will become Co-Chairs.

We hope you will join us for what promises to be an engaging educational event.